← Back to Search

Moderna Booster Recommendation for Coronavirus Pandemic (BOOSTED Trial)

N/A
Waitlist Available
Led By Greg Marcus, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

BOOSTED Trial Summary

This trial aims to investigate the long-term effects of mixing and matching vaccine-booster approaches and to provide more conclusive evidence on each regiment to guide booster recommendations.

Eligible Conditions
  • Coronavirus Pandemic
  • COVID-19
  • Coronavirus
  • Vaccine Reaction

BOOSTED Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post-Vaccine Differences in Severity of Symptoms between Homologous vs Heterologous Regiments
Post-Vaccine Differences in Severity of Symptoms between Pfizer and Moderna
Post-Vaccine Differences in Types of Symptoms between Homologous vs Heterologous Regiments
+1 more
Secondary outcome measures
COVID-19 Infection Rates between Homologous vs Heterologous Regiments
COVID-19 Infection Rates between Pfizer and Moderna

BOOSTED Trial Design

2Treatment groups
Active Control
Group I: Moderna Booster RecommendationActive Control1 Intervention
Participants assigned to this arm will be recommended to receive the Moderna vaccine for their Covid-19 booster shot.
Group II: Pfizer Booster RecommendationActive Control1 Intervention
Participants assigned to this arm will be recommended to receive the Pfizer vaccine for their Covid-19 booster shot.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,505 Previous Clinical Trials
15,237,254 Total Patients Enrolled
Greg Marcus, MDPrincipal InvestigatorUniversity of California, San Francisco
1 Previous Clinical Trials
200 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there available openings for participants in this trial?

"As reported on clinicaltrials.gov, the current recruitment window for this particular trial has closed. Initially posted on January 18th 2022 and last edited October 6th 2022, applications are no longer being accepted at present; however 1039 other trials remain open to enlistment presently."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
The BOOSTED (Booster Options Or Switching Tested for Effectiveness and Downsides Study) Trial (COVID-19)
2022. "The BOOSTED (Booster Options Or Switching Tested for Effectiveness and Downsides Study) Trial (COVID-19)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05268185.
~93 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top